Acute myocardial infarction following erlotinib treatment for NSCLC: A case report.

about

In Silico Pharmacoepidemiologic Evaluation of Drug-Induced Cardiovascular Complications Using Combined Classifiers.

P2860

Q55339567-8A72C530-5CA2-4252-BE60-3842FA677C9F

P2860

Acute myocardial infarction following erlotinib treatment for NSCLC: A case report.

Item

http://www.wikidata.org/entity/Q41843998

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Acute myocardial infarction following erlotinib treatment for NSCLC: A case report.

@en

type

Item

label

Acute myocardial infarction following erlotinib treatment for NSCLC: A case report.

@en

prefLabel

Acute myocardial infarction following erlotinib treatment for NSCLC: A case report.

@en

P1476

Acute myocardial infarction following erlotinib treatment for NSCLC: A case report.

@en

P2093

Fei Long

http://www.w3.org/2001/XMLSchema#string

Shanshan Ding

http://www.w3.org/2001/XMLSchema#string

Shujuan Jiang

http://www.w3.org/2001/XMLSchema#string

P2860

Multi-parameter in vitro toxicity testing of crizotinib, sunitinib, erlotinib, and nilotinib in human cardiomyocytes

An official American Thoracic Society/European Respiratory Society statement: the role of the pulmonologist in the diagnosis and management of lung cancer

Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib.

Cardiotoxicity induced by tyrosine kinase inhibitors.

Reviewing the safety of erlotinib in non-small cell lung cancer.

Efficacy and safety of first-line erlotinib in elderly patients with advanced non-small cell lung cancer.

Erlotinib in advanced non-small cell lung cancer: efficacy and safety findings of the global phase IV Tarceva Lung Cancer Survival Treatment study.

Efficacy and safety of maintenance erlotinib in Asian patients with advanced non-small-cell lung cancer: a subanalysis of the phase III, randomized SATURN study.

[Four cases of interstitial lung disease induced by erlotinib and a review of the literatures].

Q57908979

P304

4240-4244

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2016.4508

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27313772

http://www.w3.org/2001/XMLSchema#string

P932

4888202

http://www.w3.org/2001/XMLSchema#string

Acute myocardial infarction following erlotinib treatment for NSCLC: A case report.

about

P2860

P2860

Acute myocardial infarction following erlotinib treatment for NSCLC: A case report.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932